Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Department:  DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Type:  Review

Results 1-20 of 43 (Search time: 0.01 seconds).

Issue DateTitleAuthor(s)
1Feb-2013A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental diseaseKu, C.S. ; Polychronakos, C.; Tan, E.K. ; Naidoo, N. ; Pawitan, Y.; Roukos, D.H.; Mort, M.; Cooper, D.N.
22003Autosomal Dominant Spinocerebellar Ataxias: An Asian PerspectiveTan E.K. 
32001Choosing dopamine agonists in Parkinson's diseaseTan E.-K. ; Jankovic J.
4Sep-2011Clinical evidence linking coffee and tea intake with Parkinson's diseasePrakash, K.M.; Tan, E.-K. 
52020Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical TrialsJang, S.E.; Qiu, L.; Chan, L.L. ; Tan, E.-K. ; Zeng, L. 
62014Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's diseaseQiu L.; Zhang W.; Tan E.K. ; Zeng L. 
72016Depression, anxiety, and apathy in Parkinson's disease: Insights from neuroimaging studiesWen M.-C. ; Chan L.L. ; Tan L.C.S. ; Tan E.K. 
8Dec-2010Development of Parkinson's disease biomarkersPrakash, K.M.; Tan, E.-K. 
92003Dopamine agonists and their role in Parkinson's disease treatmentTan E.-K. 
102003Emerging therapeutic applications of botulinum toxinThant Z.-S.; Tan E.-K. 
112013From the periphery to centre stage: De novo single nucleotide variants play a key role in human genetic diseaseKu, C.-S.; Tan, E.K. ; Cooper, D.N.
122006Genetic testing in Parkinson disease: Promises and pitfallsTan E.-K. ; Jankovic J.
132001Genetic testing in spinocerebellar ataxias: Defining a clinical roleTan E.-K. ; Ashizawa T.
142020Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's DiseaseChao, Y.-X.; Gulam, M.Y.; Chia, N.S.J.; Feng, L. ; Rotzschke, O.; Tan, E.-K. 
152002Hemifacial spasm and involuntary facial movementsTan N.-C.; Chan L.-L.; Tan E.-K. 
162006Identification of a common genetic risk variant (LRRK2 Gly2385Arg) in Parkinson's DiseaseTan E.-K. 
172016Induced pluripotent stem cells in Parkinson's disease: Scientific and clinical challengesXiao B.; Hui Ng H. ; Takahashi R.; Tan E.-K. 
182017Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseasesZhou Z.D. ; Tan E.-K. 
192012Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidencePeeraully T.; Tan E.-K. 
202015microRNAs and Neurodegenerative DiseasesQiu L.; Tan E.K. ; Zeng L.